Abstract:Background: Influenza viruses (IVs) have become increasingly resistant to antiviral drugs that target neuraminidase and matrix protein 2 due to gene mutations that alter their drug-binding target protein regions. Consequently, almost all recent IV pandemics have exhibited resistance to commercial antiviral vaccines. To overcome this challenge, an antiviral target is needed that is effective regardless of genetic mutations. Main body: In particular, hemagglutinin (HA), a highly conserved surface protein across many IV strains, could be an effective antiviral target as it mediates binding of IVs with host cell receptors, which is crucial for membrane fusion. HA has 6 disulfide bonds that can easily bind with the surfaces of gold nanoparticles. Herein, we fabricated porous gold nanoparticles (PoGNPs) via a surfactant-free emulsion method that exhibited strong affinity for disulfide bonds due to gold-thiol interactions, and provided extensive surface area for these interactions. A remarkable decrease in viral infectivity was demonstrated by increased cell viability results after exposing MDCK cells to various IV strains (H1N1, H3N2, and H9N2) treated with PoGNP. Most of all, the viability of MDCK cells infected with all IV strains increased to 96.8% after PoGNP treatment of the viruses compared to 33.9% cell viability with non-treated viruses. Intracellular viral RNA quantification by real-time RT-PCR also confirmed that PoGNP successfully inhibited viral membrane fusion by blocking the viral entry process through conformational deformation of HA. Conclusion: We believe that the technique described herein can be further developed for PoGNP-utilized antiviral protection as well as metal nanoparticle-based therapy to treat viral infection. Additionally, facile detection of IAV can be achieved by developing PoGNP as a multiplatform for detection of the virus.

An Inhalable Nanoshield for Effective Prevention of Influenza Virus Infections

Prevention of influenza virus infection and transmission by intranasal administration of a porous maltodextrin nanoparticle-formulated vaccine

Inhaled Penindolone-Loaded Nanoparticles Outperform Oseltamivir for Suppression of Influenza A Virus Infection

In Vitro and in Vivo Protection Against the Highly Pathogenic H5N1 Influenza Virus by an Antisense Phosphorothioate Oligonucleotide

Chemically Modified Bovine β-Lactoglobulin as a Broad-Spectrum Influenza Virus Entry Inhibitor with the Potential to Combat Influenza Outbreaks

An inhaled bioadhesive hydrogel to shield non-human primates from SARS-CoV-2 infection

Inhibition of influenza virus infection in mice by pulmonary administration of a spray dried antiviral drug

Exploring the Inhibitory Effect of AgBiS2 Nanoparticles on Influenza Viruses

Targeted recruitment of immune effector cells for rapid eradication of influenza virus infections

Substantial Antiviral Potential of Deoxyribozymes Fixed on Anatase Nanoparticles Against Influenza A Viruses in vitro and in vivo

Porous gold nanoparticles for attenuating infectivity of influenza A virus

Covalent Organic Framework-Based Theranostic Platforms for Restricting H1N1 Influenza Virus Infection

Intranasal mask for protecting the respiratory tract against viral aerosols

Biomimetic Nanoparticles As Universal Influenza Vaccine

Thiolated Chitosan Encapsulation Constituted Mucoadhesive Nanovaccine Confers Broad Protection Against Divergent Influenza A Viruses

Development of Broad-spectrum β-cyclodextrins-Based Nanomaterials Against Influenza Viruses

Synthesis and Pharmacodynamic Evaluation of Naphthalene Derivatives Against Influenza A Virus in Vitro and in Vivo.

Intranasal Administration of Chitosan Against Influenza A (H7N9) Virus Infection in a Mouse Model

Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway

Constructing a Ready-to-Use mRNA Vaccine Delivery System for the Prevention of Influenza A virus, Utilizing FDA-Approved Raw Materials

CD388: A universally protective Drug-Fc Conjugate that targets influenza virus neuraminidase